Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RIMA KANG

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1619269578
CMS profile
437877
Location
COLUMBUS, OH

General Payments · PY2018–2024

$28,580.62

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,049.76

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $368.33 3
PY2019 $5,690.98 12
PY2020 $1,502.03 4
PY2021 $3,985.00 2
PY2022 $3,422.22 6
PY2023 $7,562.30 11
PY2024 $6,049.76 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
NXSTAGE MEDICAL, INC. $18.84 10/02/2024 Food and Beverage Undisputed 01/23/2026 1154283741 CMS
Otsuka America Pharmaceutical, Inc. $24.00 04/23/2024 Food and Beverage Undisputed 01/23/2026 1118918534 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $274.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118837567 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $1,940.00 05/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118837569 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $96.94 09/18/2024 Food and Beverage Undisputed 01/23/2026 1118837571 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $3,686.00 09/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1118837573 CMS
Travere Therapeutics, Inc. $3.08 01/26/2024 Education Undisputed 01/23/2026 1149888956 CMS
Travere Therapeutics, Inc. $0.37 05/29/2024 Education Undisputed 01/23/2026 1149888948 CMS
Travere Therapeutics, Inc. $3.08 05/29/2024 Education Undisputed 01/23/2026 1149888960 CMS
Travere Therapeutics, Inc. $3.08 10/01/2024 Education Undisputed 01/23/2026 1149888964 CMS
Travere Therapeutics, Inc. $0.37 10/16/2024 Education Undisputed 01/23/2026 1149888952 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.